Lemaitre Vascular (LMAT) Tops Q4 EPS by 2c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $87.92 --0%
Financial Fact:
Total operating expenses: 11.68M
Today's EPS Names:
SENEA, XFOR, MG, More
Financial Fact:
Total operating expenses: 11.68M
Today's EPS Names:
SENEA, XFOR, MG, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.68, $0.02 better than the analyst estimate of $0.66. Revenue for the quarter came in at $64.45 million versus the consensus estimate of $62.98 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2026 revenue of $65.6-67.6 million, versus the consensus of $65.85 million.
Lemaitre Vascular sees FY2026 revenue of $276-284 million, versus the consensus of $270.5 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Frontdoor, Inc. (FTDR) Tops Q3 EPS by 4c ; Offers Guidance
- Commerce.com, Inc. (CMRC) Tops Q3 EPS by 4c ; Offers Guidance
- 1stdibs.Com, Inc. (DIBS) Tops Q3 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
